Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Debt to Equity (2016 - 2026)

Ekso Bionics Holdings has reported Debt to Equity over the past 13 years, most recently at $0.31 for Q4 2025.

  • On a quarterly basis, Debt to Equity rose 2.49% to $0.31 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.31, a 2.49% increase, with the full-year FY2025 number at $0.31, up 2.49% from a year prior.
  • Debt to Equity reached $0.31 in Q4 2025 per EKSO's latest filing, roughly flat from $0.31 in the prior quarter.
  • The five-year high for Debt to Equity was $0.38 in Q4 2023, with the low at $0.05 in Q2 2021.
  • The 5-year median for Debt to Equity is $0.28 (2024), against an average of $0.21.
  • Peak YoY movement for Debt to Equity: plummeted 92.28% in 2021, then skyrocketed 194.83% in 2023.
  • Tracing EKSO's Debt to Equity over 5 years: stood at $0.05 in 2021, then skyrocketed by 176.5% to $0.15 in 2022, then soared by 158.88% to $0.38 in 2023, then decreased by 20.87% to $0.3 in 2024, then increased by 2.49% to $0.31 in 2025.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.31, $0.31, and $0.31 for Q4 2025, Q3 2025, and Q2 2025 respectively.